Human Papilloma
Virus Clinical Trial
Updated: 09/15/2005
Contributions will support a phase 3 clinical trial of an
Human Papilloma Virus vaccine in Costa
Rica by the National Cancer
Institute's Division of Cancer Epidemiology and Genetics.
GlaxoSmithKline Biologicals
Donors
who contributed between January 1 and December 31, 2004
are listed above. If we have erred in spelling or listing
your name, please contact the Foundation at 301-402-5311
so that we can correct our records.
|